Image For Activity Cover
Transcatheter Versus Surgical Aortic Valve Replacement in Young, Low-Risk Patients With Severe Aortic Stenosis ( JACC Cardiovascular Interventions June 2021)
Transcatheter aortic valve replacement (TAVR) is approved for all patient risk profiles and is an option for all patients irrespective of age. However, patients enrolled in the low- and intermediate-risk trials were in their 70s, and in high-risk trials in their 80s.


JACC: Cardiovascular Interventions Editor-in-Chief

David J. Moliterno, MD, FACC

JACC: Cardiovascular Interventions CME/MOC/ECME Editor

Michael C. McDaniel, MD


Charan Yerasi, MD
Toby Rogers, MD, PhD
Ron Waksman, MD

Important Dates

Date of Release: June 7, 2021
Term of Approval/Date of CME/MOC/ECME Expiration: June 6, 2022

Availability: On-Demand
Expires on Jun 06, 2022
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 ECME Credit
Android App Download IOS App Download Powered By